GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Acro Biomedical Co Ltd (OTCPK:ACBM) » Definitions » Ending Cash Position

Acro Biomedical Co (Acro Biomedical Co) Ending Cash Position : $0.00 Mil (As of Jun. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Acro Biomedical Co Ending Cash Position?

Acro Biomedical Co's Ending Cash Position for the quarter that ended in Jun. 2023 was $0.00 Mil.

Acro Biomedical Co's quarterly Ending Cash Position declined from Dec. 2022 ($0.01 Mil) to Mar. 2023 ($0.00 Mil) but then increased from Mar. 2023 ($0.00 Mil) to Jun. 2023 ($0.00 Mil).

Acro Biomedical Co's annual Ending Cash Position increased from Dec. 2020 ($0.02 Mil) to Dec. 2021 ($0.10 Mil) but then declined from Dec. 2021 ($0.10 Mil) to Dec. 2022 ($0.01 Mil).


Acro Biomedical Co Ending Cash Position Historical Data

The historical data trend for Acro Biomedical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acro Biomedical Co Ending Cash Position Chart

Acro Biomedical Co Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Dec20 Dec21 Dec22
Ending Cash Position
Get a 7-Day Free Trial - - 0.02 0.10 0.01

Acro Biomedical Co Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.02 0.01 - -

Acro Biomedical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Acro Biomedical Co's Ending Cash Position for the fiscal year that ended in Dec. 2022 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.095+-0.089
=0.01

Acro Biomedical Co's Ending Cash Position for the quarter that ended in Jun. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.001+0.002
=0.00


Acro Biomedical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Acro Biomedical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Acro Biomedical Co (Acro Biomedical Co) Business Description

Traded in Other Exchanges
N/A
Address
12175 Visionary Way, Suite 1160, Fishers, IN, USA, 46038
Acro Biomedical Co Ltd develops and manufactures nutritional products. The company offers cordyceps fungus for medicinal purposes. It also sells cordycepin and cordyceps powder.
Executives
Pao-chi Chu director, 10 percent owner, officer: CEO 2F, NO. 356 SEC 1. DUNHUA S. RD., DA'AN DISTRICT, TAIPEI CITY F5 106

Acro Biomedical Co (Acro Biomedical Co) Headlines

No Headlines